| Market Cap | 383M 336M 309M 290M 543M 36.11B 554M 3.72B 1.44B 17.85B 1.44B 1.41B 61.88B | P/E 2026 * |
42.1x | P/E 2027 * | 11.6x |
|---|---|---|---|---|---|
| Enterprise Value | 383M 336M 309M 290M 543M 36.11B 554M 3.72B 1.44B 17.85B 1.44B 1.41B 61.88B | EV / Sales 2026 * |
5.48x | EV / Sales 2027 * | 3.81x |
| Free-Float |
81.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fennec Pharmaceuticals Inc
| 1 day | +1.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeffrey Hackman
CEO | Chief Executive Officer | 64 | 2024-08-15 |
Robert Andrade
DFI | Director of Finance/CFO | 51 | 2010-01-05 |
Pierre Sayad
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 72 | 2011-08-24 |
Khalid Islam
CHM | Chairman | 69 | 2015-12-08 |
Marco Brughera
BRD | Director/Board Member | 70 | 2016-08-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.29% | +3.66% | - | - | 383M | |
| +7.13% | +9.97% | +55.80% | +160.09% | 1,077B | |
| +3.99% | +11.50% | +67.09% | +55.96% | 613B | |
| +4.20% | +17.03% | +38.97% | +91.06% | 448B | |
| +0.99% | +4.85% | +28.17% | +23.89% | 332B | |
| +1.82% | +8.19% | +40.04% | +27.95% | 293B | |
| +0.22% | +6.75% | +31.30% | +42.34% | 286B | |
| +0.73% | +8.53% | -27.33% | -39.55% | 215B | |
| +1.56% | +6.14% | +29.30% | +60.97% | 193B | |
| +3.26% | +3.33% | +15.55% | +68.24% | 159B | |
| Average | +2.52% | +8.00% | +30.99% | +54.55% | 401.79B | |
| Weighted average by Cap. | +3.85% | +8.93% | +41.75% | +80.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 69.83M 61.22M 56.43M 52.83M 99.07M 6.59B 101M 678M 262M 3.26B 262M 256M 11.29B | 100M 88.07M 81.18M 76M 143M 9.48B 145M 976M 378M 4.68B 377M 369M 16.24B |
| Net income | 8.99M 7.88M 7.27M 6.8M 12.75M 848M 13.02M 87.33M 33.79M 419M 33.76M 33.02M 1.45B | 33.1M 29.02M 26.75M 25.04M 46.96M 3.12B 47.94M 322M 124M 1.54B 124M 122M 5.35B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
